Stephen Jensik to Graft Survival
This is a "connection" page, showing publications Stephen Jensik has written about Graft Survival.
Connection Strength
0.289
-
Efficacy and safety of bleselumab in kidney transplant recipients: A phase 2, randomized, open-label, noninferiority study. Am J Transplant. 2020 01; 20(1):159-171.
Score: 0.167
-
A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. Transplantation. 2002 Mar 15; 73(5):775-82.
Score: 0.049
-
Outcomes after combined liver-kidney transplant vs. kidney transplant followed by liver transplant. Clin Transplant. 2015 Jan; 29(1):60-6.
Score: 0.030
-
A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year. Transplantation. 2005 Aug 15; 80(3):303-9.
Score: 0.016
-
An open-label, pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in established renal allograft recipients with moderate renal insufficiency. Clin Transplant. 2005 Feb; 19(1):130-6.
Score: 0.015
-
Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months. Transplantation. 2003 Apr 27; 75(8):1213-20.
Score: 0.013